361 related articles for article (PubMed ID: 32320695)
21. Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.
Sison SDM; Lin KJ; Najafzadeh M; Ko D; Patorno E; Bessette LG; Zakoul H; Kim DH
J Am Geriatr Soc; 2023 Oct; 71(10):3179-3188. PubMed ID: 37354026
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
23. The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.
Yao Y; Guo Y; Lip GYH;
JAMA Netw Open; 2021 Dec; 4(12):e2140071. PubMed ID: 34932104
[TBL] [Abstract][Full Text] [Related]
24. Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
O'Neal WT; Claxton JS; Sandesara PB; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
J Am Coll Cardiol; 2018 Oct; 72(16):1913-1922. PubMed ID: 30309468
[TBL] [Abstract][Full Text] [Related]
25. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease.
Lopes RD; Thomas L; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Friend K; Mardekian J; Pan X; Yuce H; Jones WS
Am J Cardiol; 2021 Jun; 148():69-77. PubMed ID: 33667438
[TBL] [Abstract][Full Text] [Related]
27. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Kipp R; Askari M; Fan J; Field ME; Turakhia MP
JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
[TBL] [Abstract][Full Text] [Related]
28. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
[No Abstract] [Full Text] [Related]
29. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Westenbrink BD; Alings M; Granger CB; Alexander JH; Lopes RD; Hylek EM; Thomas L; Wojdyla DM; Hanna M; Keltai M; Steg PG; De Caterina R; Wallentin L; van Gilst WH
Am Heart J; 2017 Mar; 185():140-149. PubMed ID: 28267467
[TBL] [Abstract][Full Text] [Related]
30. Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.
Deitelzweig S; Keshishian A; Li X; Kang A; Dhamane AD; Luo X; Balachander N; Rosenblatt L; Mardekian J; Pan X; Nadkarni A; Di Fusco M; Garcia Reeves AB; Yuce H; Lip GYH
J Am Geriatr Soc; 2019 Aug; 67(8):1662-1671. PubMed ID: 31112292
[TBL] [Abstract][Full Text] [Related]
31. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA
Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551
[TBL] [Abstract][Full Text] [Related]
32. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
33. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
35. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
[TBL] [Abstract][Full Text] [Related]
37. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
[TBL] [Abstract][Full Text] [Related]
38. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.
Martinez BK; Bunz TJ; Eriksson D; Meinecke AK; Sood NA; Coleman CI
ESC Heart Fail; 2019 Feb; 6(1):10-15. PubMed ID: 30299591
[TBL] [Abstract][Full Text] [Related]
40. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
